STING Signaling and Skin Cancers
Recent developments in immunotherapy against malignancies overcome the disadvantages of traditional systemic treatments; however, this immune checkpoint treatment is not perfect and cannot obtain a satisfactory clinical outcome in all cases. Therefore, an additional therapeutic option for malignancy...
Guardado en:
Autores principales: | Sayaka Sato, Yu Sawada, Motonobu Nakamura |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/213e675a67a3485d89049a4159422752 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The clinical and molecular significance associated with STING signaling in breast cancer
por: Eileen E. Parkes, et al.
Publicado: (2021) -
Hypoxia Regulates Endogenous Double-Stranded RNA Production via Reduced Mitochondrial DNA Transcription
por: Esther Arnaiz, et al.
Publicado: (2021) -
Lipid Nanocarriers for Hyperproliferative Skin Diseases
por: Eliana B. Souto, et al.
Publicado: (2021) -
Use of Intraoperative Frozen Section in the Surgical Management of Patients with Nonmelanoma Skin Cancer
por: LiAnn Loh, et al.
Publicado: (2021) -
Type I Interferon Promotes Antitumor T Cell Response in CRPC by Regulating MDSC
por: Lilv Fan, et al.
Publicado: (2021)